A surgeon shares his unique perspectives on how minimally invasive surgery has changed over the past 20 years, the biggest obstacles currently standing in the way of taking minimally invasive and robotic surgery to the next level, and a...
CEO Bryan Hanson said the company's funnel for Rosa placements is the strongest it's ever been and the surgical robotics system is expected to be a key growth driver for ZB in 2020.
Back in 2013, analysts balked at the price Stryker paid to acquire Mako, but the company just reported its strongest robot quarter since the launch of its ever popular surgical robot.
The surgical robotics pioneer is seeing some impact from increasing noise level in the market, but CEO Gary Guthart says the company is "well-positioned to have a conversation about that" as customers listen to competing pitches.
Johnson & Johnson is slated to offer a preview of its surgical robotics solution strategy in May during its Medical Device Business Review Day in New York.
The New Brunswick, N.J.-based company said it would acquire the remaining stake in Verb Surgical, a joint venture the company has with Verily.
Zimmer Biomet, MD+DI's 2019 Medtech Company of the Year, stood out from the rest because of its impressive turnaround efforts.
The Boston-based company has been granted breakthrough device designation from FDA and it has tapped former Verb Surgical CEO Scott Huennekens to be on its board.
Fresh on the heels of its FDA clearance, Xact Robotics raised $36 million to support the U.S. launch and continued development of its hands-free robot.
Here are seven key moments in 2019 that will shape the surgical robotics market for years to come.